Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Current Opinion in Drug Discovery & Development|April 1, 2009
Risk reduction in biotherapeutic productsCharles R Ill, Houman Dehghani
Current Opinion in Biotechnology|September 30, 2022
Product-safety considerations in allogeneic chimeric antigen-receptor T-cell process flowsBryan Dransart, Houman Dehghani, Alison Moore
Biologicals : Journal of the International Association of Biological Standardization|February 16, 2010
Cross comparison of rapid mycoplasma detection platformsBill Lawrence, Houman Bashiri, Houman Dehghani
PDA Journal of Pharmaceutical Science and Technology|February 2, 2012
Evaluation of a single-platform, rapid, nucleic Acid-based technology for detection of adventitious contaminants of cell cultureHouman Dehghani, Bill Lawrence, Richard C Ill
PDA Journal of Pharmaceutical Science and Technology|September 5, 2014
Use of MMV as a Single Worst-Case Model Virus in Viral Filter Validation StudiesEva Gefroh, Houman Dehghani, Megan McClure, et al.
Biotechnology and Bioengineering|October 19, 2023
Detection of Minute virus of mice strains in different cell lines: Implications for adventitious agent testingMaria R Farcet, Jens Modrof, Gerhard Antoine, et al.
Pageof 2